Non-Current Assets
Other Non-Current Assets
Edwards Lifesciences Other Non-Current Assets increased by 1.2% to $738.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $742.70M to $738.90M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 43.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
Significant changes may indicate shifts in accounting estimates, tax positions, or non-core asset holdings.
Detailed definition
This category includes long-term assets that do not fit into specific classifications like PP&E or intangibles, such as...
Peer comparison
Standard line item in most balance sheets, often labeled 'Other non-current assets'.
Metric ID:
non_current_assets_other_assets_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $105.30M | $133.70M | $110.80M | $129.40M | $234.70M | $316.50M | $299.10M | $293.60M | $412.10M | $447.40M | $463.70M | $767.60M | $789.80M | $683.50M | $721.60M | $742.70M | $743.00M | $784.80M | $730.20M | $738.90M |
| QoQ Change | — | +27.0% | -17.1% | +16.8% | +81.4% | +34.9% | -5.5% | -1.8% | +40.4% | +8.6% | +3.6% | +65.5% | +2.9% | -13.5% | +5.6% | +2.9% | +0.0% | +5.6% | -7.0% | +1.2% |
| YoY Change | — | — | — | — | +122.9% | +136.7% | +169.9% | +126.9% | +75.6% | +41.4% | +55.0% | +161.4% | +91.7% | +52.8% | +55.6% | -3.2% | -5.9% | +14.8% | +1.2% | -0.5% |
Range$105.30M – $789.80M
CAGR+50.7%
Avg YoY Growth+68.5%
Median YoY Growth+55.3%
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's other non-current assets?
- Edwards Lifesciences (EW) reported other non-current assets of $738.90M in Q1 2026.
- How has Edwards Lifesciences's other non-current assets changed year-over-year?
- Edwards Lifesciences's other non-current assets decreased by 0.5% year-over-year, from $742.70M to $738.90M.
- What is the long-term trend for Edwards Lifesciences's other non-current assets?
- Over 5 years (2020 to 2025), Edwards Lifesciences's other non-current assets has grown at a 43.6% compound annual growth rate (CAGR), from $119.60M to $730.20M.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into standard categories.